Results 261 to 270 of about 143,384 (302)

Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours

Nature Reviews Clinical Oncology, 2022
, Giedre Krenciute, Dimitrios L Wagner
exaly  

Target Costing

1994
Uwe Groth, Andreas Kammel
openaire   +3 more sources

The cGAS–STING pathway as a therapeutic target in inflammatory diseases

Nature Reviews Immunology, 2021
Alexiane Decout, Andrea Ablasser
exaly  

Target Costing

1999
Dietger Hahn, Gert Laßmann
openaire   +1 more source

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

Target Costing

2022
openaire   +1 more source

2. Zielkostenmanagement - Target Costing, Target Cost Management

1999
openaire   +1 more source

Target Costing

2019
M. Bradford Clifton, Wesley P. Townsend, Henry M.B. Bird, Robert E. Albano   +3 more
openaire   +1 more source

A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control

Ca-A Cancer Journal for Clinicians, 2019
Otis W Brawley, Ted Gansler, Robert A Smith   +2 more
exaly  

Target Costing

2001
openaire   +1 more source